What is thalidomide, and what is it used for?
Thalidomide is a prescription drug best known for its historical role in causing severe birth defects when used during pregnancy. Today, it is used in specific, tightly controlled medical settings. It is commonly prescribed for certain cancers and blood disorders, including multiple myeloma, where it is used in combination with other medicines. [1][2]
Why was thalidomide restricted so strongly?
Thalidomide became infamous because exposure during pregnancy can cause serious congenital malformations. As a result, regulators required strict pregnancy prevention measures and a controlled distribution system to prevent fetal exposure. [1]
How does thalidomide work (and why does it help in multiple myeloma)?
In multiple myeloma treatment regimens, thalidomide helps by affecting pathways involved in cancer cell growth and the tumor environment. It has immune-modulating and anti-angiogenic effects (it can influence blood vessel formation and immune signaling), which is part of why it can improve outcomes when used in the right combinations. [2]
What are the main side effects patients ask about?
Common concerns with thalidomide include sedation or fatigue, constipation, and nerve-related symptoms such as peripheral neuropathy (tingling, numbness, or pain in the hands and feet). The risk of blood clots is also a major concern, especially when used with other agents in multiple myeloma regimens. [2][3]
Why do doctors test and monitor more than usual?
Because of teratogenic risk (birth defects), pregnancy prevention steps are central to safe prescribing. Patients who can become pregnant typically must use effective contraception and follow documented pregnancy-testing requirements before, during, and after treatment. Monitoring for nerve symptoms and clot risk is also standard practice due to thalidomide’s known safety profile. [1][3]
What happens if someone accidentally takes thalidomide during pregnancy?
Exposure during pregnancy is associated with severe fetal harm, so pregnancy prevention programs are designed to reduce the chance of exposure as much as possible. If pregnancy occurs while taking thalidomide, clinicians manage it urgently under specialist guidance and with strict safety procedures. [1]
Is thalidomide still available, and how do regulations affect access?
Yes, thalidomide remains available as a prescription medicine in controlled use cases, but access is restricted by pregnancy prevention and prescribing rules. The distribution system is designed to ensure only appropriate patients receive it and that pregnancy risk controls are followed. [1]
What are alternatives to thalidomide in multiple myeloma?
Multiple myeloma treatment now often uses other agents that can be combined in different regimens. The choice depends on disease status, prior therapies, patient age, and safety considerations such as clot risk and neuropathy. For many patients, clinicians weigh whether thalidomide’s specific risk-benefit profile is the best option compared with alternatives. [2]
---
Sources
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/thalidomide-risk-evaluation-and-mitigation-strategy-rems
[2] https://www.cancer.gov/publications/dictionaries/cancer-drug/thalidomide
[3] https://www.ema.europa.eu/en/medicines/human/EPAR/thalidomide-throughput